Assay ID | Title | Year | Journal | Article |
AID1119086 | Displacement of [3H]DADLE from human delta opioid receptor expressed in CHO cell membrane after 2 hrs by liquid scintillation counting analysis | 2011 | MedChemComm, Dec, Volume: 2, Issue:12
| Potential Drug Abuse Therapeutics Derived from the Hallucinogenic Natural Product Salvinorin A. |
AID1119085 | Displacement of [3H]DAMGO from human mu opioid receptor expressed in CHO cell membrane after 2 hrs by liquid scintillation counting analysis | 2011 | MedChemComm, Dec, Volume: 2, Issue:12
| Potential Drug Abuse Therapeutics Derived from the Hallucinogenic Natural Product Salvinorin A. |
AID321650 | Displacement of [3H]diprenorphine from human kappa opioid receptor expressed in CHO cells | 2008 | Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
| Standard protecting groups create potent and selective kappa opioids: salvinorin B alkoxymethyl ethers. |
AID321654 | Agonist activity at human kappa opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding relative to U50488H | 2008 | Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
| Standard protecting groups create potent and selective kappa opioids: salvinorin B alkoxymethyl ethers. |
AID321653 | Agonist activity at human kappa opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding | 2008 | Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
| Standard protecting groups create potent and selective kappa opioids: salvinorin B alkoxymethyl ethers. |
AID321652 | Displacement of [3H]diprenorphine from mouse delta opioid receptor expressed in CHO cells | 2008 | Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
| Standard protecting groups create potent and selective kappa opioids: salvinorin B alkoxymethyl ethers. |
AID321656 | Selectivity for human kappa opioid receptor over mouse delta opioid receptor | 2008 | Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
| Standard protecting groups create potent and selective kappa opioids: salvinorin B alkoxymethyl ethers. |
AID321651 | Displacement of [3H]diprenorphine from rat mu opioid receptor expressed in CHO cells | 2008 | Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
| Standard protecting groups create potent and selective kappa opioids: salvinorin B alkoxymethyl ethers. |
AID1119088 | Agonist activity at human kappa opioid receptor expressed in CHO cell membrane assessed as [35S]GTPgammaS binding after 3 hrs by liquid scintillation counting analysis | 2011 | MedChemComm, Dec, Volume: 2, Issue:12
| Potential Drug Abuse Therapeutics Derived from the Hallucinogenic Natural Product Salvinorin A. |
AID1119089 | Agonist activity at human kappa opioid receptor expressed in CHO cell membrane assessed as [35S]GTPgammaS binding after 3 hrs by liquid scintillation counting analysis relative to (-)-U50488H | 2011 | MedChemComm, Dec, Volume: 2, Issue:12
| Potential Drug Abuse Therapeutics Derived from the Hallucinogenic Natural Product Salvinorin A. |
AID1119087 | Displacement of [3H]U69593 from human kappa opioid receptor expressed in CHO cell membrane after 2 hrs by scintillation counting analysis | 2011 | MedChemComm, Dec, Volume: 2, Issue:12
| Potential Drug Abuse Therapeutics Derived from the Hallucinogenic Natural Product Salvinorin A. |
AID321655 | Selectivity for human kappa opioid receptor over rat mu opioid receptor | 2008 | Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
| Standard protecting groups create potent and selective kappa opioids: salvinorin B alkoxymethyl ethers. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |